Tumor markers and neutrophil-lymphocyte ratio’s predictive role in endometriosis

Year 2020, Volume: 15 Issue: 2, 20 - 23, 08.07.2020

Ayhan Atıgan , Ömer Tolga Güler

https://doi.org/10.17517/ksutfd.607197

Abstract

Objective: Endometriosis is characterized by the
development of endometrial tissue outside the uterine cavity. Aim of this study
is to investigate the diagnostic value of neutrophil/lymphocyte ratio
(NLR)  and cancer antigen (CA)-125 in a
diagnosis of endometriosis.

Material and methods: In this retrospective
study, the medical data of a total of  30
patients who underwent surgery due to endometriosis between January 2012 to
December 2017 at Pamukkale University were analyzed.

Results: NLR and CA-125 were increased in the
patients with endometriosis.

Conclusion: A diagnostic test without the need
for surgery will reduce the associated surgical risks, increase accessibility
to a diagnostic test and improve treatment outcomes.

Keywords

Endometriosis, neutrophil/lymphocyte ratio, tumor markers

Endometriozis’te tümör marker ve nötrofil-lenfosit oranının prediktif rolü

Abstract

Amaç: Endometriozis, uterin kavite dışında
endometrial dokunun gelişimi ile karakterizedir.Bu çalışmanın amacı,
endometriozis tanısında nötrofil / lenfosit oranı (NLO) ve kanser antijeni (CA)
-125'in tanısal değerini araştırmaktır.

Gereç ve Yöntem: Bu retrospektif çalışmada, Ocak 2012
- Aralık 2017 tarihleri arasında Pamukkale Üniversitesi'nde endometriozis
nedeniyle ameliyat edilen toplam 30 hastanın tıbbi verileri analiz edildi.

Bulgular: Endometriozisli hastalarda NLO ve CA-125
arttı.

Sonuç: Cerrahiye yapılmadan uygulanan tanısal bir
test cerrahi ilişkili riskleri azaltır. Tanısal testin uygulanabilirliğini
arttırır ve tedavi sonuçlarını iyileştirir.

 

Keywords

Endometriozis, nötrofil/lenfosit oranı, tümör belirteçleri

References

• 1. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99.
• 2. Giudice LC, Clinical practice Endometriosis. N. Engl. J. Med. 2010;362:2389–98.
• 3. Mounsey AL, Wilgus A, Slawson DC. Diagnosis and management of endometriosis. American Family Physician. 2006;74:594–600.
• 4. Wellbery C. Diagnosis and treatment of endometriosis. American Family Physician. 1999; 60:1753–62.
• 5. Barbieri RL, Niloff JM, Bast Jr. RC, Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986;45:630–4.
• 6. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16: 651–74.
• 7. Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S et al. New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol 2011;27:73–9.
• 8. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18:177–200.
• 9. Yang H, Lang JH, Zhu L, Wang S, Sha GH, Zhang Y. Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis. Chin Med J 2013;126:2011-14.
• 10. Tazegül A, Acar A. Klinigimizde Gerceklestirilen Histerektomi Olgularının Klinik ve Demografik Ozelliklerinin Degerlendirilmesi. Selçuk Tıp Derg 2010;26:19-22.
• 11. Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the noninvasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; CD012179.
• 12. Cho S, Cho H, Nam A, Kim HY, Choi YS, Park KH, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril 2008;90:2073-9.
• 13. Fassbender A, Burney RO, O DF, et al. Update on biomarkers for the detection of endometriosis. Biomed Res Int 2015;13:08-54.